+81-29-889-3870
: System no.-method no. is linked to number described in Table S2 . We used two LC-MS/MS systems in this study as follows: system no. 1, a TripleQuad6500 (AB SCIEX, Tokyo, Japan) equipped with an Agilent 1290 system (Agilent Technologies, Tokyo, Japan); system no. 2, an API4000 triple quadrupole mass spectrometer (AB SCIEX) equipped with an Agilent 1100 system (Agilent Technologies). Plasma_no.: Plasma_1, plasma without β-glucuronidase treatment; plasma_2, plasma with β-glucuronidase treatment. DP; declustering potential, CE; collision energy, CXP; collision cell exit potential. 
HPLC condition

1-1
Column: CAPCELL CORE ADME (100 × 2.1 mm I.D., 2.7-μm particle size; Shiseido, Tokyo, Japan) Guard column: CORE ADME EXP cartridge (5 × 2.1 mm I.D., 2.7-μm particle size; LC-MS/MS system: system no. 1, a TripleQuad6500 (AB SCIEX) equipped with an Agilent 1290 system (Agilent Technologies); system no. 2, an API4000 triple quadrupole mass spectrometer (AB SCIEX) equipped with an Agilent 1100 system (Agilent Technologies).
